Schneiderian papillomas are uncommon benign tumors of the sinonasal area. They are prone to local aggressiveness and recurrence, and some undergo malignant progression. We analyzed specimens obtained from 67 Chinese patients who had presented to the ENT department of a regional hospital with biopsy-proven schneiderian papilloma. Seven of these patients had either synchronous or metachronous carcinoma, 1 of whom had pure carcinoma in situ. For each case, we documented the morphology, immunohistochemical expression of tumor suppressor genes p53 and p16, and any association with human papillomavirus (HPV) infection as detected by either polymerase chain reaction or in situ hybridization techniques. We found that severe dysplasia and p53 positivity were strongly associated with malignant progression. Association with HPV was demonstrated in 22 of the 67 patients (33%); the association was strongest among patients with exophytic papillomas and carcinomas. The effect of HPV in papilloma oncogenesis probably begins during the early phase, while other factors are responsible for progression to carcinoma. We conclude that p53-positive, dysplastic schneiderian papillomas warrant aggressive surgical treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1177/014556131008901002DOI Listing

Publication Analysis

Top Keywords

schneiderian papillomas
12
papillomas carcinomas
8
p53 p16
8
tumor suppressor
8
association hpv
8
malignant progression
8
schneiderian
4
carcinomas retrospective
4
retrospective study
4
study special
4

Similar Publications

 Sinonasal inverted papilloma (SNIP) is a rare benign epithelial tumor of the nasal cavity and paranasal sinuses that accounts for 0.4% and 4.7% respectively, of all tumors of this anatomical region.

View Article and Find Full Text PDF

Purpose: DEK::AFF2 fusion-associated squamous cell carcinoma (DEK::AFF2 SCC), also reported in the literature as low-grade papillary sinonasal (Schneiderian) carcinoma (LGPSC), is a rare, primarily bland-appearing, but locally aggressive neoplasm. Morphologically, these tumors can closely resemble sinonasal papilloma (SP), especially on small or limited biopsy, often leading to misdiagnosis. DEK::AFF2 SCC is devoid of the underlying mutually exclusive EGFR or KRAS driver mutations of SP, suggesting it may represent a distinct unique entity.

View Article and Find Full Text PDF

An inverted papilloma is a rare, benign tumor that affects the nasal cavity and paranasal sinuses. The maxillary and ethmoid sinuses are the most commonly affected, while the involvement of the sphenoid sinus is rare and may be associated with malignancy. We describe the case of a 21-year-old female who presented with recurring headaches along with dizziness, difficulty concentrating, mild hypoacusis, and occasional nasal congestion.

View Article and Find Full Text PDF

Objectives: There is growing interest in assessing patient quality of life (QOL) following treatment of sinonasal tumors, including inverted papilloma (IP). We aimed to elucidate the natural history of postoperative QOL outcomes in IP patients treated with surgery.

Methods: Cases of sinonasal IP treated surgically at 4 tertiary academic rhinology centers were retrospectively reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess a minimally invasive surgical technique that combines endoscopic and eyelid crease approaches for treating recurrent sino-orbital mucoceles, in collaboration with oculoplastic and sinus surgeons.
  • Review of 18 cases revealed that most patients had prior sinus or orbital surgeries, with complications such as cellulitis and proptosis, but only two cases (11%) of recurrence after an average follow-up of 19 months.
  • The findings suggest that this surgical method is effective for advanced sino-orbital conditions, offering low recurrence rates and minimal complications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!